X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with Torrent Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs TORRENT PHARMA - Comparison Results

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. TORRENT PHARMA FDC LTD./
TORRENT PHARMA
 
P/E (TTM) x 17.2 25.0 68.6% View Chart
P/BV x 3.6 6.1 58.4% View Chart
Dividend Yield % 1.3 3.3 40.6%  

Financials

 FDC LTD.   TORRENT PHARMA
EQUITY SHARE DATA
    FDC LTD.
Mar-14
TORRENT PHARMA
Mar-16
FDC LTD./
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs1441,720 8.3%   
Low Rs791,134 7.0%   
Sales per share (Unadj.) Rs47.6394.5 12.1%  
Earnings per share (Unadj.) Rs7.6101.8 7.5%  
Cash flow per share (Unadj.) Rs9.0116.3 7.7%  
Dividends per share (Unadj.) Rs2.2540.00 5.6%  
Dividend yield (eoy) %2.02.8 72.1%  
Book value per share (Unadj.) Rs47.5200.3 23.7%  
Shares outstanding (eoy) m177.83169.22 105.1%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.33.6 64.7%   
Avg P/E ratio x14.614.0 104.3%  
P/CF ratio (eoy) x12.312.3 100.7%  
Price / Book Value ratio x2.37.1 32.9%  
Dividend payout %29.639.3 75.2%   
Avg Mkt Cap Rs m19,784241,435 8.2%   
No. of employees `000NA10.9 0.0%   
Total wages/salary Rs m1,2218,559 14.3%   
Avg. sales/employee Rs ThNM6,129.6-  
Avg. wages/employee Rs ThNM785.8-  
Avg. net profit/employee Rs ThNM1,581.3-  
INCOME DATA
Net Sales Rs m8,45966,764 12.7%  
Other income Rs m3942,156 18.3%   
Total revenues Rs m8,85268,920 12.8%   
Gross profit Rs m2,07027,204 7.6%  
Depreciation Rs m2492,461 10.1%   
Interest Rs m311,859 1.7%   
Profit before tax Rs m2,18425,041 8.7%   
Minority Interest Rs m00 0.0%   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m0-1,403 0.0%   
Tax Rs m6066,414 9.4%   
Profit after tax Rs m1,35317,224 7.9%  
Gross profit margin %24.540.7 60.1%  
Effective tax rate %27.725.6 108.3%   
Net profit margin %16.025.8 62.0%  
BALANCE SHEET DATA
Current assets Rs m4,35546,622 9.3%   
Current liabilities Rs m1,79232,843 5.5%   
Net working cap to sales %30.320.6 146.8%  
Current ratio x2.41.4 171.2%  
Inventory Days Days4474 59.9%  
Debtors Days Days2579 31.2%  
Net fixed assets Rs m3,02539,029 7.8%   
Share capital Rs m179846 21.1%   
"Free" reserves Rs m8,24331,400 26.3%   
Net worth Rs m8,45333,890 24.9%   
Long term debt Rs m1118,637 0.1%   
Total assets Rs m10,55790,136 11.7%  
Interest coverage x71.414.5 493.5%   
Debt to equity ratio x00.5 0.2%  
Sales to assets ratio x0.80.7 108.2%   
Return on assets %13.121.2 61.9%  
Return on equity %16.050.8 31.5%  
Return on capital %23.548.5 48.4%  
Exports to sales %13.343.3 30.7%   
Imports to sales %3.36.9 48.7%   
Exports (fob) Rs m1,12628,934 3.9%   
Imports (cif) Rs m2834,584 6.2%   
Fx inflow Rs m1,14629,185 3.9%   
Fx outflow Rs m3556,021 5.9%   
Net fx Rs m79123,165 3.4%   
CASH FLOW
From Operations Rs m1,48527,132 5.5%  
From Investments Rs m-620-7,014 8.8%  
From Financial Activity Rs m-753-14,352 5.2%  
Net Cashflow Rs m1135,767 2.0%  

Share Holding

Indian Promoters % 68.9 71.5 96.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 7.0 67.0%  
FIIs % 7.5 12.6 59.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 8.8 215.9%  
Shareholders   23,730 26,511 89.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   ALKEM LABORATORIES  FRESENIUS KABI ONCO.  GLENMARK PHARMA  ASTRAZENECA PHARMA  DISHMAN PHARMA  

Compare FDC LTD. With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Green; Lupin up 4%(01:30 pm)

After opening the day flat, share markets in India remained rangebound and are presently trading marginally above the dotted line.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Aug 24, 2017 01:52 PM

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. - NATCO PHARMA COMPARISON

COMPARE FDC LTD. WITH

MARKET STATS